Amit Sachdev - 10 Feb 2026 Form 4 Insider Report for VERTEX PHARMACEUTICALS INC / MA (VRTX)

Role
EVP Chief Patient & Ext Af Off
Signature
/s/ Christiana Stevenson, Attorney-in-Fact
Issuer symbol
VRTX
Transactions as of
10 Feb 2026
Net transactions value
-$963,519
Form type
4
Filing time
12 Feb 2026, 17:06:16 UTC
Previous filing
26 Jan 2026
Next filing
18 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Sachdev Amit EVP Chief Patient & Ext Af Off C/O VERTEX PHARMACEUTICALS INCORPORATED, 50 NORTHERN AVENUE, BOSTON /s/ Christiana Stevenson, Attorney-in-Fact 12 Feb 2026 0001406338

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VRTX Common Stock Tax liability $963,519 -2,057 -2.9% $468.41 68,941 10 Feb 2026 Direct
holding VRTX Common Stock 882 10 Feb 2026 401(k)
holding VRTX Common Stock 9,301 10 Feb 2026 Held in Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.